Denmeade SR, Jakobsen CM, Janssen S, Khan SR, Garrett ES, Lilja H, Christensen SB, Isaacs JT. Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer. JNCI Journal of the National Cancer Institute. 2003 Jul 02;95(13):990–1000. doi: 10.1093/jnci/95.13.990.